Taro Pharmaceutical Industries Ltd. (TARO) to Release Earnings on Monday
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) is scheduled to be posting its quarterly earnings results after the market closes on Monday, November 6th.
Taro Pharmaceutical Industries Ltd. (TARO) opened at 108.33 on Monday. The stock has a 50 day moving average of $109.27 and a 200 day moving average of $110.59. Taro Pharmaceutical Industries Ltd. has a 52 week low of $92.28 and a 52 week high of $124.52. The company has a market cap of $4.39 billion, a price-to-earnings ratio of 11.03 and a beta of 0.65.
Several research firms have recently issued reports on TARO. BidaskClub downgraded Taro Pharmaceutical Industries from a “buy” rating to a “hold” rating in a research note on Thursday, October 12th. TheStreet raised Taro Pharmaceutical Industries from a “c” rating to a “b-” rating in a research note on Thursday, July 20th.
COPYRIGHT VIOLATION NOTICE: This article was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/10/30/taro-pharmaceutical-industries-ltd-taro-to-release-earnings-on-monday.html.
Taro Pharmaceutical Industries Company Profile
Taro Pharmaceutical Industries Ltd. (Taro) is a science-based pharmaceutical company. The Company operates principally through three entities: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries, Taro Pharmaceuticals Inc (Taro Canada) and Taro U.SA The Company markets over 200 pharmaceutical products in over 25 countries.
Receive News & Ratings for Taro Pharmaceutical Industries Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Taro Pharmaceutical Industries Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.